FDA OKs Pfizer booster for ages 12-15, shortens booster window to 5 months
MORGANTOWN – The FDA took three steps Monday to make Pfizer COVID vaccine boosters more widely available. It expanded the booster age to include children ages 12-15. It reduced the wait time for a booster – for age 12 and up – from six months to five months. And for immunocompromised ...